THU 29 OCTEvening7:33 AM

Back to the brief

BIZCNBC

Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

Read the original report

Opens CNBC in a new tab